IL6 and chronic kidney disease: Patients with chronic kidney disease (CKD) display higher serum levels of oxLDL, characterized by an hyperinflammatory phenotype of monocytes accompanied by an increased production of pro-inflammatory cytokines (i.e., TNF-α, IL-1β and IL-6) [128,129,130,131].